KIF11 and cancer: While EG5 is upregulated in cancer cells, microtubule-targeting chemotherapeutic agents, such as paclitaxel simultaneously upregulate Eg5 in healthy tissues, contributing to side effects, including CIPN, and possibly gastrointestinal distress and alopecia (Fig. 6c).